A product containing macitentan, or a pharmaceutically acceptable salt of this compound, for use in the treatment of malignant glioma in combination with a cytotoxic therapy agent, with radiotherapy or with both a cytotoxic therapy agent and radiotherapy. A product according to claim 1 , wherein the malignant glioma are glioblastoma multiforme.